Diarrheas syndrome in real clinical practice: topical aspects of differential diagnostics and correction


DOI: https://dx.doi.org/10.18565/therapy.2020.2.145-155

Trukhan D.I., Viktorova I.A., Ivanova D.S.

Omsk State Medical University of the Ministry of Healthcare of Russia
Diarrhea is one of the most common syndromes encountered in the practice of a general practitioner, general practitioner, pediatrician, gastroenterologist and infectious diseases specialist. Chronic diarrhea can be a clinical manifestation of not only digestive diseases. The first part of this review discusses the differential diagnosis of chronic diarrhea syndrome in real clinical practice.
A change in the quantitative and qualitative composition of the intestinal microflora is noted for any chronic diarrhea, therefore, correction of intestinal microbiocenosis disorders is a necessary component of the correction of these patients. In the second part, an analysis of the composition and therapeutic capabilities of the new synbiotic VitaStrong® Florioza is carried out.
Keywords: Florioza, inulin, intestinal microbiocenosis disorders, synbiotics, correction, prebiotics, B vitamins, probiotics, diarrhea, differential diagnosis
Read entire article

Literature


  1. Циммерман Я.С. Синдром диареи: состояние проблемы. Клиническая медицина. 2009; 3: 18–25. [Tsimmerman Ya.S. Diarrheic syndrome: state of the problem. Klinicheskaya meditsina. 2009; 3: 18–25 (In Russ.)].

  2. Циммерман Я.С. Гастроэнтерология: руководство. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа. 2015; 816 с. [Tsimmerman Ya. S. Gastroenterology: guide. 2nd issue (revised and expanded). M.: GEOTAR-Media. 2015. 816 p. (In Russ.)].

  3. Тарасова Л.В., Трухан Д.И. Болезни кишечника. Клиника, диагностика и лечение. СПб.: СпецЛит. 2013. 144 с. [Tarasova L.V., Trukhan D.I. Bowel diseases. Clinical signs, diagnosis and treatment. SPb.: SpecLit. 2013; 144 p. (In Russ.)].

  4. Трухан Д.И., Киселева Д.С., Тарасова Л.В. Диарея: актуальные вопросы дифференциальной диагностики. Consilium Medicum. Гастроэнтерология. 2014; 1: 51–54. [Trukhan D.I., Kiseleva D.S., Tarasova L.V. Diarrhea: current issues of differential diagnosis. Consilium Medicum. Gastroenterology. 2014; 1: 51–54. (In Russ.)].

  5. Трухан Д.И., Тарасова Л.В., Киселева Д.С. Диарея: диагностическая тактика врача общей практики. Справочник врача общей практики. 2015; 3: 9–17. [Trukhan D.I., Tarasova L.V., Kiseleva D.S. Diarrhea: diagnostic tactics of general practitioner. Spravochnik vracha obshchej praktiki. 2015; 3: 9–17 (In Russ.)].

  6. Щербенков И.М. Синдром острой диареи в практике врача-терапевта. Справочник поликлинического врача. 2009; 7: 44–50. [Shcherbenkov I.M. Acute diarrheal syndrome in the therapeutic practice. Spravochnik poliklinicheskogo vracha. 2009; 7: 44–50 (In Russ.)].

  7. Захарова И.Н., Андрюхина Е.Н., Дмитриева Ю.А. Инфекционные и неинфекционные диареи у детей: тактика врача-педиатра. Consilium medicum. Педиатрия. 2012; 4: 40–44. [Zakharova I.N., Andryukhina E.N., Dmitrieva Yu.A. Infectious and non-infectious diarrhea in children: pediatrician tactics. Consilium medicum. Pediatrics. 2012; 4: 40–44 (In Russ.)].

  8. Шрайнер Е.В. Лечение острой диареи: от теории к практике. Русский медицинский журнал. 2013; 17: 912–916. [Shrajner E.V. Treatment of acute diarrhea: from theory to practice. Russkiy meditsinskiy zhurnal. 2013; 17: 912–916 (In Russ.)].

  9. Трухан Д.И., Киселева Д.С. Дифференциальная диагностика диареи. Справочник поликлинического врача. 2015; 9: 18–21. [Trukhan D.I., Kiseleva D.S. Differential diagnosis of diarrhea. Spravochnik poliklinicheskogo vracha. 2015; 09: 18–21 (In Russ.)].

  10. Щербенков И.М. Хроническая диарея в педиатрической практике. Consilium medicum. Педиатрия. 2010; 2: 55–59 [Shcherbenkov I.M. Chronic diarrhea in the pediatric practice. Consilium medicum. Pediatrics. 2010; 2: 55–59 (In Russ.)].

  11. Урсова Н.И. Синдром хронической диареи: диагностическая и терапевтическая тактика. Фарматека. 2012; 1; 17–23 [Ursova N.I. Chronic diarrhea: diagnostic and therapeutic tactics. Farmateka. 2012; 1; 17–23. (In Russ.)].

  12. Тарасова Л.В., Трухан Д.И. Дифференциальная диагностика при диарее. Экспериментальная и клиническая гастроэнтерология. 2015; 12: 105–110. [Tarasova L.V., Trukhan D.I. Diagnostic algorithm for diarrhea. Eksperimental'naya i klinicheskaya gastroenterologiya. 2012; 11: 105–110 (In Russ.)].

  13. Трухан Д.И., Филимонов С.Н. Дифференциальный диагноз основных гастроэнтерологических синдромов и симптомов. М.: Практическая медицина. 2016; 168 с. [Trukhan D.I., Filimonov S.N. Differential diagnosis of major gastroenterological syndromes and symptoms. M.: Prakticheskaja medicina. 2016. 168 p. (In Russ.)].

  14. Парфенов А.И., Крумс Л.М. Холагенная диарея: особенности патогенеза, клиники и лечения. Русский медицинский журнал. 2009; 2: 114–118. [Parfenov A.I., Krums L.M. Chologenic diarrhea: features of pathogenesis, clinical signs and treatment. Russkij medicinskij zhurnal. 2009; 2: 114–118 (In Russ.)].

  15. Трухан Д.И., Викторова И.А., Лялюкова Е.А. Болезни желчного пузыря и желчевыводящих путей. СПб.: СпецЛит. 2011; 127 с. [Trukhan D.I., Viktorova I.A., Lyalyukova E.A. Diseases of the gallbladder and biliary tract. SPb.: SpetsLit. 2011. 127 p. (In Russ.)].

  16. Трухан Д.И., Филимонов С.Н., Тарасова Л.В. Клиника, диагностика и лечение основных заболеваний желчного пузыря и желчевыводящих путей. Новокузнецк: ООО «Полиграфист». 2013; 111 с. [Trukhan D.I., Filimonov S.N., Tarasova L.V. Clinical signs, diagnosis and treatment of major diseases of gallbladder and bile duct. Novokuzneck: Poligrafist LLC. 2013; 111 p. (In Russ.)].

  17. Трухан Д.И., Тарасова Л.В. Клиника, диагностика и лечение хронического дуоденита. Экспериментальная и клиническая гастроэнтерология. 2012; 11: 104–114. [Trukhan D.I., Tarasova L.V. The clinical symptoms, diagnostics and treatment of chronic duodenitis Eksperimental'naya i klinicheskaya gastroenterologiya. 2012; 11: 104–114 (In Russ.)].

  18. Бельмер С.В. Целиакия у детей [Электронный ресурс]. С.В. Бельмер, М.О. Ревнова. 2-е, перераб. и доп. изд. М.: Медпрактика-М. 2013; 416 с. Режим доступа: https://www.books-up.ru/ru/book/celiakiya-u-detej-3677016. [Belmer S.V. Coeliac disease in Children [Electronic resource]. Belmer S.V., Revnova M.O. 2nd issue (revised and expanded). M.: Medpraktika-M. 2013; 416 p. (In Russ.) Available at: https://www.books-up.ru/ru/book/celiakiya-u-detej-3677016].

  19. Парфенов А.И. Диагностика и лечение энтеропатий. Русский медицинский журнал. 2013; 13: 731–736. [Parfenov A.I. Diagnosis and treatment of enteropathy. Russkij medicinskij zhurnal. 2013; 13: 731–736 (In Russ.)].

  20. Трухан Д.И., Филимонов С.Н. Заболевания кишечника: клиника, диагностика и лечение. Новокузнецк: ООО «Полиграфист». 2017; 223 с. [Trukhan D.I., Filimonov S.N. Bowel diseases: clinical signs, diagnosis and treatment. Novokuzneck: Poligrafist LLC. 2017; 223 p. (In Russ.)].

  21. Левченко С.В. Этиология и патогенез дивертикулярной болезни толстой кишки. Экспериментальная и клиническая гастроэнтерология. 2011; 2: 93–96. [Levchenko S.V. Etiology and pathogenesis of diverticular disease of the colon. Eksperimental'naya i klinicheskaya gastroenterologiya. 2011; 2: 93–96 (In Russ.)].

  22. Левченко С.В., Лазебник Л.Б. Медикаментозная терапия неосложненной симптоматической дивертикулярной болезни толстой кишки. Consilium Medicum. 2014; 08: 21–23. Levchenko S.V., Lazebnik L.B. Drug therapy of uncomplicated symptomatic diverticular colon disease. Consilium Medicum. 2014; 08: 21–23 (In Russ.)].

  23. Drossman D.A., Hasler W.L. Rome IV – Functional GI disorders: disorders of Gut-Brain interaction. Gastroenterology. 2016 May; 150(6): 1257–61. doi: 10.1053/j.gastro.2016.03.035.

  24. Lacy B.E., Patel N.K. Rome Criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017 Oct 26; 6(11). pii: E99. doi: 10.3390/jcm6110099.

  25. Ивашкин В.Т., Шелыгин Ю.А., Баранская Е.К. с соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России по диагностике и лечению синдрома раздраженного кишечника. Российский журнал гастроэнтерологии, гепатологии и колопроктологии. 2017; 27(5): 76–93. [Ivashkin V.T., Shelygin Yu.A., Baranskaya Ye.K. et al. Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology. Rossiyskiy zhurnal gastroenterologii gepatologii i koloproktologii. 2017; 27(5): 76–93. (In Russ.)].

  26. Трухан Д.И., Голошубина В.В., Иванова Д.С. Актуальные вопросы диагностики и лечения синдрома раздраженного кишечника. Медицинский совет. 2018; 21: 110–116 [Trukhan D.I., Goloshubina V.V., Ivanova D.S. Actual issues of diagnosis and treatment of irritable bowel syndrome. Medicinskiy sovet. 2018; 21: 110–116 (In Russ.)]. doi: https://doi.org/10.21518/2079-701X-2018-21-110-116.

  27. Трухан Д.И., Тарасова Л.В., Трухан Л.Ю. Гастроэнтерологические нарушения у пациентов с сахарным диабетом. Справочник врача общей практики. 2013; 8: 51–59. [Trukhan D.I., Tarasova L.V., Trukhan L.Yu. Gastroenterological disorders in patients with diabetes mellitus. Spravochnik vracha obshchey praktiki. 2013; 8: 51–59 (In Russ.)].

  28. Трухан Д.И., Голошубина В.В., Трухан Л.Ю. Изменения верхних отделов желудочно-кишечного тракта у пациентов с сахарным диабетом: актуальные вопросы диагностики, лечения и контроля. Справочник поликлинического врача. 2014; 11: 40–43. [Trukhan D.I., Goloshubina V.V., Trukhan L.Yu. Changes in upper gastrointestinal tract in patients with diabetes mellitus: actual issues of diagnosis, treatment and control. Spravochnik poliklinicheskogo vracha. 2014; 11: 40–43 (In Russ.)].

  29. Трухан Д.И., Викторова И.А. Нефрология. Эндокринология. Гематология. СПб.: СпецЛит. 2017. 253 с. [Trukhan D.I., Viktorova I.A. Nephrology. Endocrinology. Hematology. SPb.: SpecLit. 2017; 253 p. (In Russ.)].

  30. Трухан Д.И., Тарасова Л.В. Железодефицитная анемия: актуальные вопросы диагностики, лечения и профилактики. Гинекология. 2013; 5: 95–99. [Trukhan D.I., Tarasova L.V. Iron-deficiency anemia: actual issues of diagnosis, treatment and prevention. Ginekologiya. 2013; 5: 95–99 (In Russ.)].

  31. Трухан Д.И. Нестероидные противовоспалительные препараты сквозь призму коморбидности и лекарственной безопасности:в фокусе – амтолметин гуацил. Consilium Medicum. 2015; 2: 27–33. [Trukhan D.I. Nonsteroidal anti-inflammatory drugs through the prism comorbidity and drug safety: in focus amtolmetin guatsil. Consilium Medicum. 2015; 17 (2): 27–33. (In Russ.)].

  32. Лузина Е.В., Ларева Н.В. Ассоциированная с антибиотиками диарея в клинической практике. Терапевтический архив. 2013; 2: 85–88. [Luzina E.V., Lareva N.V. Antibiotic-associated diarrhea in clinical practice. Terapevticheskiy arkhiv. 2013; 2: 85–88 (In Russ.)].

  33. Weng M.T., Chiu Y.T, Wei P.Y. et al. Microbiota and gastrointestinal cancer. J Formos Med Assoc. 2019 Mar; 118 Suppl 1: S32–S41. doi: 10.1016/j.jfma.2019.01.002.

  34. Pourmasoumi M., Najafgholizadeh A., Hadi A. et al. The effect of synbiotics in improving Helicobacter pylori eradication: A systematic review and meta-analysis. Complement Ther Med. 2019 Apr; 43: 36-43. doi: 10.1016/j.ctim.2019.01.005.

  35. Roselli M., Finamore A. Use of synbiotics for ulcerative colitis treatment. Curr Clin Pharmacol. 2019 Dec 26. doi: 10.2174/1574884715666191226120322.

  36. Ghafouri A., Zarrati M., Shidfar F. et al. Effect of synbiotic bread containing lactic acid on glycemic indicators, biomarkers of antioxidant status and inflammation in patients with type 2 diabetes: a randomized controlled trial. Diabetol Metab Syndr. 2019 Dec 5; 11: 103. doi: 10.1186/s13098-019-0496-9.

  37. Manzanares W., Lemieux M., Langlois P.L., Wischmeyer P.E. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care. 2016 Aug 19; 19: 262. doi: 10.1186/s13054-016-1434-y.

  38. Sebastian Domingo J.J. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterol Hepatol. 2017 Jun–Jul; 40(6): 417–29. doi: 10.1016/j.gastrohep.2016.12.003.

  39. Агафонова И.А., Яковенко Э.П., Иванов А.Н. с соавт. Особенности терапии больных с постинфекционным синдромом раздраженного кишечника. Фарматека. 2011; 15: 50–55. [Agafonova N.A., Yakovenko E.P., Ivanov A.N. et al. Features of therapy of patients with post-infectious irritable bowel syndrome. Farmateka. 2011; 15: 50–55 (In Russ.)].

  40. Timmerman H.M., Koning C.J., Mulder L. et al. Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol. 2004 Nov 15; 96(3): 219–33. doi: 10.1016/j.ijfoodmicro.2004.05.012.

  41. Illiano P., Brambilla R., Parolini C. The mutual interplay of gut microbiota, diet and human disease. FEBS J. 2020 Jan 19. doi: 10.1111/febs.15217.

  42. Kim S.Y. Irritable bowel syndrome and synbiotics. Korean J Fam Med. 2019 Jan; 40(1): 1. doi: 10.4082/kjfm.40.1E.

  43. Salvucci E. The human-microbiome superorganism and its modulation to restore health. Int J Food Sci Nutr. 2019 Nov; 70(7): 781–95. doi: 10.1080/09637486.2019.1580682.

  44. Oka A., Sartor R.B. Microbial-based and microbial-targeted therapies for inflammatory bowel diseases. Dig Dis Sci. 2020 Jan 31. doi: 10.1007/s10620-020-06090-z.

  45. Cresci G.A.M. Lampe J.W., Gibson G. Targeted approaches for in situ gut microbiome manipulation. JPEN J Parenter Enteral Nutr. 2020 Feb 6. doi: 10.1002/jpen.1779.

  46. Трухан Д.И., Голошубина В.В., Трухан Л.Ю. Изменения со стороны органов и тканей полости рта при гастроэнтерологических заболеваниях. Экспериментальная и клиническая гастроэнтерология. 2015; 3: 90–93. [Trukhan D.I., Goloshubina V.V., Trukhan L.Yu. Changes in the organs and tissues of the oral cavity with digestive system diseases. Eksperimental'naya i klinicheskaya gastroenterologiya. 2015; 3: 90–93 (In Russ.)].

  47. Трухан Д.И., Лебедев О.И., Сулимов А.Ф., Трухан Л.Ю. Изменение органа зрения, кожи и слизистых оболочек при заболеваниях кишечника. Терапия. 2018; 2: 34–40. [Trukhan D I., Lebedev O I., Sulimov A.Ph., Trukhan L.Yu. Change of the organ of vision, skin and mucosium shells in diseases of the intestine. Therapy. 2018; 2: 34–40 (In Russ.)].

  48. Cox A.J., West N.P., Horn P.L. et al. Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adults. Eur J Clin Nutr. 2014 Nov; 68(11): 1255–57. doi: 10.1038/ejcn.2014.137.

  49. Хавкин А.И., Комарова О.Н. Эффективность поликомпонентных пробиотических препаратов, включающих штаммы Lactobacillus acidophilus LA-14, Lactobacillus reuteri и Bifidobacterium lactis при функциональных нарушениях пищеварения у детей раннего возраста: результаты проспективного, открытого, наблюдательного исследования. Экспериментальная и клиническая гастроэнтерология. 2017; 141 (5): 57–64. [Khavkin A.I., Komarova O.N. The effectiveness of polycomponent probiotics including strains of lactobacillus acidophilus la-14, lactobacillus reuteri and bifidobacterium lactis in functional gastrointestinal disorders in early aged children: the results of a prospective, open, observational study. Eksperimental’naya i klinicheskaya gastroenterologiya. 2017; 141 (5): 57–64 (In Russ.)].

  50. Barker A.K., Duster M., Valentine S. et al. A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO). J Antimicrob Chemother. 2017 Nov 1; 72(11): 3177–80. doi: 10.1093/jac/dkx254.

  51. Miyazima T.Y., Ishikawa K.H., Mayer M. et al. Cheese supplemented with probiotics reduced the Candida levels in denture wearers – RCT. Oral Dis. 2017 Oct; 23(7): 919–25. doi: 10.1111/odi.12669.

  52. De Wolfe T.J., Eggers S., Barker A.K. et al. Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection. PLoS One. 2018 Sep 28; 13(9): e0204253. doi: 10.1371/journal.pone.0204253.

  53. Gomes A.C., Hoffmann C., Mota J.F. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera. Eur J Nutr. 2019 Jun 27. doi: 10.1007/s00394-019-02034-0.

  54. Airaksinen K., Yeung N., Lyra A. et al. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial. Benef Microbes. 2019 May 27: 1–12. doi: 10.3920/BM2018.0163.

  55. Morovic W., Roper J.M., Smith A.B. et al. Safety evaluation of HOWARU® Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity. Food Chem Toxicol. 2017 Dec; 110: 316–24. doi: 10.1016/j.fct.2017.10.037.

  56. Morovic W., Roos P., Zabel B. et al. Transcriptional and functional analysis of Bifidobacterium animalis subsp. lactis exposure to tetracycline. Appl Environ Microbiol. 2018 Nov 15; 84(23). pii: e01999–18. doi: 10.1128/AEM.01999-18. Print 2018 Dec 1.

  57. Todorov S.D., Furtado D.N., Saad S.M. et al. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain. New Microbiol. 2011 Oct; 34(4): 357–70.

  58. Martinez F.A., Domínguez J.M., Converti A., Oliveira R.P. Production of bacteriocin-like inhibitory substance by Bifidobacterium lactis in skim milk supplemented with additives. J Dairy Res. 2015 Aug; 82(3): 350–55. doi: 10.1017/S0022029915000163.

  59. Paineau D., Carcano D., Leyer G. et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 2008 Jun; 53(1): 107–13. doi: 10.1111/j.1574-695X.2008.00413.x.

  60. Guandalini S., Pensabene L., Zikri M.A. et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000; 30(1): 54–60. doi: 10.1097/00005176-200001000-00018.

  61. Rosenfeldt V., Michaelsen K.F., Jakobsen M. et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J. 2002; 21(5): 411–16. doi: 10.1097/00006454-200205000-00012.

  62. Teran C.G., Teran-Escalera C.N., Villarroel P. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int J Infect Dis. 2009 Jul; 13(4): 518–23. doi: 10.1016/j.ijid.2008.09.014.

  63. Liu F., Wen K., Li G. et al. Dual functions of Lactobacillus acidophilus NCFM as protection against rotavirus diarrhea. J Pediatr Gastroenterol Nutr. 2014 Feb; 58(2): 169–76. doi: 10.1097/MPG.0000000000000197.

  64. West N.P., Horn P.L., Pyne D.B. et al. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin Nutr. 2014 Aug; 33(4): 581–87. doi: 10.1016/j.clnu.2013.10.002.

  65. Turner R.B., Woodfolk J.A., Borish L. et al. Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection – a randomised controlled trial. Benef Microbes. 2017 Apr 26; 8(2): 207–15. doi: 10.3920/BM2016.0160.

  66. Del Popolo G., Nelli F. Recurrent bacterial symptomatic cystitis: a pilot study on a new natural option for treatment. Arch Ital Urol Androl. 2018 Jun 30; 90(2): 101–03. doi: 10.4081/aiua.2018.2.101.

  67. De Alberti D., Russo R., Terruzzi F. et al. Lactobacilli vaginal colonisation after oral consumption of Respecta(®) complex: a randomised controlled pilot study. Arch Gynecol Obstet. 2015 Oct; 292(4): 861–67. doi: 10.1007/s00404-015-3711-4.

  68. Jang S.E., Jeong J.J., Choi S.Y. et al. Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-infected bacterial vaginosis in mice. Nutrients. 2017 May 23; 9(6). pii: E531. doi: 10.3390/nu9060531.

  69. Bendazzoli C., Turroni S., Gotti R. et al. Determination of oxalyl-coenzyme a decarboxylase activity in Oxalobacter formigenes and Lactobacillus acidophilus by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1; 854(1–2): 350–56. doi: 10.1016/j.jchromb.2007.04.027.

  70. Giardina S., Scilironi C., Michelotti A. et al. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria. J Food Sci. 2014 Mar; 79(3): M384–90. doi: 10.1111/1750-3841.12344.

  71. Kelly G. Inulin-type prebiotics--a review: part 1. Altern Med Rev. 2008 Dec; 13(4): 315–29.

  72. Mensink M.A., Frijlink H.W., van der Voort Maarschalk K., Hinrichs W.L. Inulin, a flexible oligosaccharide. II: review of its pharmaceutical applications. Carbohydr Polym. 2015 Dec 10; 134: 418–28. doi: 10.1016/j.carbpol.2015.08.022.

  73. Shoaib M., Shehzad A., Omar M. et al. Inulin: Properties, health benefits and food applications. Carbohydr Polym. 2016 Aug 20; 147: 444–54. doi: 10.1016/j.carbpol.2016.04.020.

  74. Scott J.M., Molloy A.M. The discovery of vitamin B(12). Ann Nutr Metab. 2012; 61(3): 239–45. doi: 10.1159/000343114.

  75. Pan Y., Liu Y., Guo H. et al. Associations between folate and vitamin B12 levels and inflammatory bowel disease: a meta-analysis. Nutrients. 2017 Apr 13; 9(4). pii: E382. doi: 10.3390/nu9040382.

  76. Трухан Д.И., Мазуров А.Л., Речапова Л.А. Острые респираторные вирусные инфекции: актуальные вопросы диагностики, профилактики и лечения в практике терапевта. Терапевтический архив. 2016; 11:76–82. [Trukhan D.I., Mazurov A.L., Rechapova L.A. Acute respiratory viral infections: topical issues of diagnosis, prevention and treatment in therapeutic practice. Terapevticheskiy arkhiv. 2016; 11: 76–82 (In Russ.)]. doi: 10.17116/terarkh2016881176-82.

  77. Трухан Д.И., Тарасова Л.В. Гельминтозы: актуальные вопросы. Consilium Medicum. 2013; 12: 52–56. [Trukhan D.I., Tarasova L.V. Helminthiasis: current issues. Consilium Medicum. 2013; 12: 52–56 (In Russ.)].

  78. Трухан Д.И., Викторова И.А. Коррекция нарушений кишечного микробиоценоза в аспекте профилактики респираторных инфекций дыхательных путей: возможности Lactobacillus rhamnosus GG. Гастроэнтерология. Хирургия. Интенсивная терапия. Consilium Medicum. 2018; 2: 39–44. [Trukhan D.I., Viktorova I.A. Correction of infringements of intestinal microbiocenosis in the aspect of prevention of respiratory infections of respiratory tract: opportunities of Lactobacillus rhamnosus GG. Gastroenterology. Surgery. Intensive care. Consilium Medicum. 2018; 2: 39–44. (In Russ.)]. doi: 10.26442/26583739.2018.2.180103.


About the Autors

Dmitry I. Trukhan, MD, associate professor of the Department of polyclinic therapy and internal diseases of Omsk State Medical University of the Ministry of Healthcare of Russia. Address: 644043, Omsk, 12 Lenina Str.
Теl.: +7 (381) 295-72-77. E-mail: dmitry_trukhan@mail.ru. ORCID 0000-0002-1597-1876
Inna A. Viktorova, MD, professor, head of the Department of polyclinic therapy and internal diseases of Omsk State Medical University of the Ministry of Healthcare of Russia. Address: 644043, Omsk, 12 Lenina Str.
Теl.: +7 (381) 295-72-77. E-mail: vic-inna@mail.ru. ORCID: 0000-0001-8728-2722
Darya S. Ivanova, PhD, associate professor of the Department of polyclinic therapy and internal diseases of Omsk State Medical University of the Ministry of Healthcare of Russia. Address: 644043, Omsk, 12 Lenina Str.
Теl.: +7 (381) 295-72-77. E-mail: darja.ordinator@mail.ru. ORCID: 0000-0002-4145-7969


Similar Articles

Back to Content

Бионика Медиа